CTRI/2022/02/040107已完成未知
An open label study to evaluate the safety and tolerability of turmeric-boswellia formulation in healthy adult volunteers
试验速览
- 阶段
- 未知
- 状态
- 已完成
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Males or Females above 18 and below 55 years of age.
- •2. Volunteer must be able, willing and likely to fully comply with study procedures and restrictions.
- •3. No clinically significant abnormalities judged by the principal investigator based on the medical history, physical examination, electrocardiogram, chest X-ray, and routine laboratory evaluations.
- •4. Individuals who have been tested negative for SARS-COV2 in a RT-PCR test.
- •5. Voluntariness to participate in the trial and give signed informed consent.
排除标准
- •1. Individuals who have been tested positive to be infected with SARS-COV2 in a RT-PCR test.
- •2. Patients with history of co-morbid illnesses such as cardiovascular, endocrine, renal, hepatic or other chronic disease likely to affect stress/anxiety or limit normal function.
- •3. Individuals with history of serious complications of diseases such as cancer, heart disease, infraction, stroke, arterial fibrillation, cardiac arrhythmia, disabilities, neurodegenerative disease.
- •4. Subjects with alcohol and/or substance dependence.
- •5. Subjects with known allergic reactions to test drug or any of its ingredients or any other herbal supplements.
- •6. Undergone surgery during last one year.
- •7. Individuals participating in any other clinical trial.
- •8. Female volunteers who are found positive in Urinary Pregnancy Test or are lactating.
- •9. Any condition, including laboratory abnormalities, that in the opinion of investigator places the volunteer at an unacceptable risk or deems the volunteer not suitable for participation in the study.
研究者
相似试验
已完成
不适用
To study the safety of Ashwagandha extract in healthy peopleCTRI/2022/08/044636Arjuna Natural Private Limited62
进行中(未招募)
1 期
A study to evaluate the safety of REN001 capsules when given for 12 weeks (with option to continue treatment) to patients with mitochondrial myopathies.EUCTR2018-002969-19-GBReneo Pharma Ltd.24
招募中
2 期
A study to investigate the safety and feasibility of delivering MDMA-assisted psychotherapy to patients with posttraumatic stress disorderPosttraumatic Stress DisorderMental Health - Other mental health disordersACTRN12623000838617Emyria Ltd5
已完成
不适用
An open label study to assess the safety and tolerability of PB006 administered as a single intravenous infusioMultiple SclerosisNL-OMON48246bioeq GmbH10
Unknown
2 期
A Clinical Study to evaluate the Safety and Efficacy of LP011-09 in subjects with Allergic RhinitisCTRI/2012/03/002473aila Pharmaceutical Pvt Ltd40
